Pre-treatment direct costs for people with tuberculosis during the COVID-19 pandemic in different healthcare settings in Bandung, Indonesia
PLOS ONE · 01.04.2025 · 20 (4) · e0320401
DOI: 10.1371/journal.pone.0320401 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 01.04.2025. Verfasst von Bony Wiem Lestari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tuberculosis Working Group, Research Center for Care and Control of Infectious Disease Universitas Padjadjaran, Bandung, Indonesia. Hauptthemen laut MEDLINE: COVID-19, Tuberculosis, Health Care Costs, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
The tuberculosis (TB) program was massively disrupted due to the COVID-19 pandemic, which may have impacted on an increase in costs for people with TB (PWTB) and their households. We aimed to quantify the pre-treatment out-of-pocket costs and the factors associated with these costs from patients’ perspective during the COVID-19 pandemic in Bandung, Indonesia. Adults with pulmonary TB were interviewed using a structured questionnaire for this cross-sectional study recruiting from 7 hospitals, 59 private practitioners, and 10 community health centers (CHCs) between July 2021 to February 2022. Costs in rupiah were converted into US dollars and presented as a median and interquartile range (IQR). Factors associated with costs were identified using quantile regression. A total of 252 participants were recruited. The median total pre-treatment cost was $35.45 (IQR 17.69-67.62). The highest median cost was experienced by participants from private hospitals ($54.51, IQR 29.48-98.47). The rapid antigen and PCR for SARS-CoV-2 emerged as additional medical costs among 26% of participants recruited in private hospitals. Visiting ≥ 6 providers before diagnosis ($38.40 versus $26.20, p < 0.001), presenting first at a private hospital ($50.68, p < 0.05) and private practitioners ($34.97, p < 0.05), and being diagnosed in the private health sector ($39.98 versus $20.30, p < 0.05) were significantly associated with higher pre-treatment costs. PWTB experienced substantial out-of-pocket costs in the process of diagnosis during the COVID-19 pandemic despite free TB diagnosis and treatment. Early detection and identification play an important role in reducing pre-diagnostic TB costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Tuberculosis Working Group, Research Center for Care and Control of Infectious Disease Universitas Padjadjaran, Bandung, Indonesia.
- Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
- Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
- McGill International TB Center, Montreal, Canada.
- McCourt School of Public Policy, Georgetown University, Washington, District of Columbia, United States of America.
ORCID-Profile: Bony Wiem Lestari, Auliya Ramanda Fikri, Angelina Sassi, Charity Oga-Omenka, Bachti Alisjahbana
Förderung
- Gates Foundation
- Bill and Melinda Gates Foundation
Zitieren
APA
Lestari, B. W., Saptiningrum, E., Huria, L., Fikri, A. R., Daniels, B., Vasquez, N. A., Sassi, A., Das, J., Oga-Omenka, C., McAllister, S. M., Pai, M., & Alisjahbana, B. (2025). Pre-treatment direct costs for people with tuberculosis during the COVID-19 pandemic in different healthcare settings in Bandung, Indonesia. PLOS ONE, 20(4), e0320401. https://doi.org/10.1371/journal.pone.0320401
Vancouver
Lestari BW, Saptiningrum E, Huria L, Fikri AR, Daniels B, Vasquez NA, et al. Pre-treatment direct costs for people with tuberculosis during the COVID-19 pandemic in different healthcare settings in Bandung, Indonesia. PLOS ONE. 2025;20(4):e0320401. doi:10.1371/journal.pone.0320401
BibTeX
@article{Lestari2025,
author = {Lestari, Bony Wiem and Saptiningrum, Eka and Huria, Lavanya and Fikri, Auliya Ramanda and Daniels, Benjamin and Vasquez, Nathaly Aguilera and Sassi, Angelina and Das, Jishnu and Oga-Omenka, Charity and McAllister, Susan M and Pai, Madhukar and Alisjahbana, Bachti},
title = {Pre-treatment direct costs for people with tuberculosis during the COVID-19 pandemic in different healthcare settings in Bandung, Indonesia},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {4},
pages = {e0320401},
doi = {10.1371/journal.pone.0320401}
}
EUVIMED